Inactivated Vaccine
Mostrando 1-12 de 336 artigos, teses e dissertações.
-
1. Comparison of severe acute respiratory syndrome coronavirus 2 (COVID-19) vaccine side effects by age groups
SUMMARY OBJECTIVE: This online survey aims to compare the side effects that may occur after inactivated severe acute respiratory syndrome coronavirus 2 (COVID-19) vaccination by age groups. METHODS: A total of 411 participants aged 18–100 who received inactivated coronavirus disease 2019 vaccine were included in the study. RESULTS: Participants were div
Revista da Associação Médica Brasileira. Publicado em: 2022
-
2. Two cases of subacute thyroiditis after different types of SARS-CoV-2 vaccination
SUMMARY Although the development of subacute thyroiditis (SAT) following viral infections is well-documented, the actual mechanism has not been clearly elucidated. The occurrence of SAT after vaccination has been reported in several case series and possible mechanisms such as molecular mimicry due to the exposure to viral proteins and/or abnormal reactogenic
Archives of Endocrinology and Metabolism. Publicado em: 2022
-
3. Serological response against bovine herpesvirus and bovine viral diarrhea virus induced by commercial vaccines in Holstein heifers
RESUMO: A vacinação é utilizada como estratégia para a prevenção e controle das doenças reprodutivas, causadas pelos vírus da diarreia viral bovina (BVDV) e herpesvírus bovino tipo 1 (BoHV-1), entretanto, as diversas composições de vacinas comerciais devem ser avaliadas quanto a sua eficiência protetiva mediada por anticorpos (Acs). O objetivo de
Pesq. Vet. Bras.. Publicado em: 02/12/2019
-
4. IMMUNIZATION STATUS OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE
RESUMO CONTEXTO: No tratamento de doenças inflamatórias intestinais (DII) são usados imunossupressores e agentes biológicos, o que aumenta o risco de infecções pela alteração da imunidade celular e humoral. A prevenção de algumas dessas infecções pode ser feita pela vacinação, entretanto pacientes com DII apresentam baixas taxas de cobertura
Arq. Gastroenterol.. Publicado em: 26/08/2019
-
5. Prospective cohort studies to evaluate the safety and immunogenicity of the 2013, 2014, and 2015 seasonal influenza vaccines produced by Instituto Butantan
ABSTRACT Annual vaccination is the most effective way to prevent seasonal influenza illness. Instituto Butantan (IB) performed clinical studies with its 2013, 2014 and 2015 seasonal trivalent influenza vaccines (inactivated split-virion). Prospective cohort studies were carried out to describe the safety and immunogenicity of Instituto Butantan influenza vac
Rev. Inst. Med. trop. S. Paulo. Publicado em: 30/07/2018
-
6. Individual variation is the key to the development of a vaccine against Staphylococcus aureus: a comparative study between mice lineages
Bacterial infections occur worldwide and are a major public health problem. Among pathogens, Staphylococcus aureus is the main causative agent of bacterial diseases in the world. This study aimed to evaluate which components of the immune system could act protectively against a S. aureus infection in intradermally immunized mice. C57BL/6 and A/j mice were im
Braz J Med Biol Res. Publicado em: 26/03/2018
-
7. Immunogenicity and safety of Southern Hemisphere inactivated quadrivalent influenza vaccine: a Phase III, open-label study of adults in Brazil
Abstract The World Health Organization influenza forecast now includes an influenza B strain from each of the influenza B lineages (B/Yamagata and B/Victoria) for inclusion in seasonal influenza vaccines. Traditional trivalent influenza vaccines include an influenza B strain from one lineage, but because two influenza B lineages frequently co-circulate, the
Braz J Infect Dis. Publicado em: 2017-02
-
8. An Alternative Inactivant for Rift Valley Fever Virus using Cobra Venom-derived L-Amino Oxidase, which is Related to its Immune Potential
ABSTRACT Vaccine improvement depends on the formulation, adjuvant type and inactivant used. The type of formulation may interfere with immunogenicity. The present work aimed to evaluate the inactivation activity and related immune potential of the Cobra venom-derived LAO enzyme compared to the currently used inactivants (BPL and formalin) for both animal and
Braz. arch. biol. technol.. Publicado em: 31/10/2016
-
9. COMPARATIVE EVALUATION OF THE PROTECTIVE EFFICACY OF DIFFERENT VACCINATION PROGRAMS AGAINST A VIRULENT FIELD STRAIN OF THE NEWCASTLE DISEASE VIRUS IN BROILERS
ABSTRACT Despite the intensive vaccination programs used for controlling Newcastle disease (ND) in the Iranian poultry industry, outbreaks of ND have been reported in poultry farms. This study was conducted to evaluate the effectiveness of vaccines for the protection against ND infection and virus-shedding period of velogenic Newcastle disease virus (vNDV) f
Rev. Bras. Cienc. Avic.. Publicado em: 2016-09
-
10. Comparative pathogenicity of Coxsackievirus A16 circulating and noncirculating strains in vitro and in a neonatal mouse model
An enterovirus 71 (EV71) vaccine for the prevention of hand, foot, and mouth disease (HMFD) is available, but it is not known whether the EV71 vaccine cross-protects against Coxsackievirus (CV) infection. Furthermore, although an inactivated circulating CVA16 Changchun 024 (CC024) strain vaccine candidate is effective in newborn mice, the CC024 strain causes
Braz J Med Biol Res. Publicado em: 27/03/2015
-
11. Vaccines for preventing herpes zoster in older adults
BACKGROUND:Herpes zoster or, as it is commonly called, 'shingles' is a neurocutaneous disease characterised by the reactivation of varicella zoster virus (VZV), the virus that causes chickenpox, which is latent in the dorsal spinal ganglia when immunity to VZV declines. It is an extremely painful condition which can often last for many weeks or months, impai
Sao Paulo Med. J.. Publicado em: 2014
-
12. Challenges in the research and development of new human vaccines
The field of vaccinology was born from the observations by the fathers of vaccination, Edward Jenner and Louis Pasteur, that a permanent, positive change in the way our bodies respond to life-threatening infectious diseases can be obtained by specific challenge with the inactivated infectious agent performed in a controlled manner, avoiding the development o
Braz J Med Biol Res. Publicado em: 2013-02